annual CAPEX:
$10.64M-$4.53M(-29.85%)Summary
- As of today (June 29, 2025), PCRX annual capital expenditures is $10.64 million, with the most recent change of -$4.53 million (-29.85%) on December 31, 2024.
- During the last 3 years, PCRX annual CAPEX has fallen by -$35.23 million (-76.81%).
- PCRX annual CAPEX is now -76.81% below its all-time high of $45.87 million, reached on December 31, 2021.
Performance
PCRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$8.55M+$6.43M(+303.59%)Summary
- As of today (June 29, 2025), PCRX quarterly capital expenditures is $8.55 million, with the most recent change of +$6.43 million (+303.59%) on March 31, 2025.
- Over the past year, PCRX quarterly CAPEX has increased by +$5.71 million (+201.41%).
- PCRX quarterly CAPEX is now -40.67% below its all-time high of $14.41 million, reached on December 31, 2020.
Performance
PCRX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$16.35M+$5.71M(+53.70%)Summary
- As of today (June 29, 2025), PCRX TTM capital expenditures is $16.35 million, with the most recent change of +$5.71 million (+53.70%) on March 31, 2025.
- Over the past year, PCRX TTM CAPEX has increased by +$4.92 million (+43.00%).
- PCRX TTM CAPEX is now -68.01% below its all-time high of $51.11 million, reached on September 30, 2021.
Performance
PCRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
PCRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -29.9% | +201.4% | +43.0% |
| 3 y3 years | -76.8% | +11.5% | -59.6% |
| 5 y5 years | +4.7% | +27.1% | +10.0% |
PCRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -76.8% | at low | -27.2% | +437.6% | -60.7% | +70.0% |
| 5 y | 5-year | -76.8% | +4.7% | -40.7% | +437.6% | -68.0% | +70.0% |
| alltime | all time | -76.8% | +93.1% | -40.7% | +1949.9% | -68.0% | +3820.4% |
PCRX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $8.55M(+303.6%) | $16.35M(+53.7%) |
| Dec 2024 | $10.64M(-29.8%) | $2.12M(-48.2%) | $10.64M(+3.1%) |
| Sep 2024 | - | $4.09M(+157.4%) | $10.32M(+7.3%) |
| Jun 2024 | - | $1.59M(-43.9%) | $9.62M(-15.9%) |
| Mar 2024 | - | $2.84M(+57.7%) | $11.43M(-24.6%) |
| Dec 2023 | $15.16M(-49.6%) | $1.80M(-47.0%) | $15.16M(-19.6%) |
| Sep 2023 | - | $3.39M(-0.3%) | $18.86M(-8.7%) |
| Jun 2023 | - | $3.40M(-48.1%) | $20.64M(-28.8%) |
| Mar 2023 | - | $6.57M(+19.5%) | $28.97M(-3.7%) |
| Dec 2022 | $30.08M(-34.4%) | $5.49M(+6.0%) | $30.08M(-10.9%) |
| Sep 2022 | - | $5.18M(-55.9%) | $33.75M(-19.0%) |
| Jun 2022 | - | $11.73M(+53.0%) | $41.65M(+2.9%) |
| Mar 2022 | - | $7.67M(-16.3%) | $40.46M(-11.8%) |
| Dec 2021 | $45.87M(+21.3%) | $9.17M(-29.9%) | $45.87M(-10.3%) |
| Sep 2021 | - | $13.08M(+23.9%) | $51.11M(+11.6%) |
| Jun 2021 | - | $10.55M(-19.3%) | $45.80M(+3.7%) |
| Mar 2021 | - | $13.07M(-9.3%) | $44.15M(+16.8%) |
| Dec 2020 | $37.80M(+272.1%) | $14.41M(+85.6%) | $37.80M(+35.5%) |
| Sep 2020 | - | $7.76M(-12.8%) | $27.89M(+28.4%) |
| Jun 2020 | - | $8.91M(+32.5%) | $21.72M(+46.1%) |
| Mar 2020 | - | $6.72M(+49.5%) | $14.87M(+46.3%) |
| Dec 2019 | $10.16M(-30.0%) | $4.50M(+182.5%) | $10.16M(+28.5%) |
| Sep 2019 | - | $1.59M(-22.4%) | $7.91M(-26.6%) |
| Jun 2019 | - | $2.05M(+1.7%) | $10.77M(-5.1%) |
| Mar 2019 | - | $2.02M(-10.0%) | $11.35M(-21.8%) |
| Dec 2018 | $14.51M(-24.7%) | $2.24M(-49.6%) | $14.51M(-16.3%) |
| Sep 2018 | - | $4.45M(+69.1%) | $17.35M(-5.3%) |
| Jun 2018 | - | $2.63M(-49.2%) | $18.31M(-12.1%) |
| Mar 2018 | - | $5.18M(+2.1%) | $20.83M(+8.1%) |
| Dec 2017 | $19.27M | $5.08M(-6.3%) | $19.27M(+1.0%) |
| Sep 2017 | - | $5.42M(+5.1%) | $19.07M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $5.16M(+42.6%) | $17.56M(-17.5%) |
| Mar 2017 | - | $3.62M(-25.9%) | $21.27M(-13.9%) |
| Dec 2016 | $24.71M(-38.7%) | $4.88M(+25.0%) | $24.71M(-14.5%) |
| Sep 2016 | - | $3.91M(-56.0%) | $28.91M(-20.8%) |
| Jun 2016 | - | $8.87M(+25.7%) | $36.51M(-7.5%) |
| Mar 2016 | - | $7.05M(-22.3%) | $39.47M(-2.0%) |
| Dec 2015 | $40.30M(+75.3%) | $9.08M(-21.1%) | $40.30M(+0.6%) |
| Sep 2015 | - | $11.51M(-2.8%) | $40.03M(+21.8%) |
| Jun 2015 | - | $11.83M(+50.3%) | $32.86M(+21.5%) |
| Mar 2015 | - | $7.87M(-10.8%) | $27.05M(+17.7%) |
| Dec 2014 | $22.98M(+88.8%) | $8.82M(+103.8%) | $22.98M(+35.5%) |
| Sep 2014 | - | $4.33M(-28.1%) | $16.96M(-2.1%) |
| Jun 2014 | - | $6.02M(+58.2%) | $17.33M(+32.8%) |
| Mar 2014 | - | $3.81M(+35.8%) | $13.05M(+7.2%) |
| Dec 2013 | $12.17M(-33.3%) | $2.80M(-40.3%) | $12.17M(-13.7%) |
| Sep 2013 | - | $4.70M(+169.9%) | $14.10M(-10.0%) |
| Jun 2013 | - | $1.74M(-40.7%) | $15.66M(-14.4%) |
| Mar 2013 | - | $2.93M(-38.0%) | $18.29M(+0.2%) |
| Dec 2012 | $18.26M(+196.0%) | $4.73M(-24.4%) | $18.26M(+14.0%) |
| Sep 2012 | - | $6.26M(+43.3%) | $16.01M(+40.4%) |
| Jun 2012 | - | $4.37M(+50.5%) | $11.40M(+38.4%) |
| Mar 2012 | - | $2.90M(+16.8%) | $8.24M(+33.5%) |
| Dec 2011 | $6.17M(-8.9%) | $2.48M(+50.6%) | $6.17M(-7.0%) |
| Sep 2011 | - | $1.65M(+37.1%) | $6.63M(-3.6%) |
| Jun 2011 | - | $1.20M(+44.6%) | $6.88M(-4.2%) |
| Mar 2011 | - | $832.00K(-71.8%) | $7.18M(+6.1%) |
| Dec 2010 | $6.77M(+22.9%) | $2.95M(+55.4%) | $6.77M(+77.2%) |
| Sep 2010 | - | $1.90M(+26.0%) | $3.82M(+98.7%) |
| Jun 2010 | - | $1.51M(+261.2%) | $1.92M(+361.2%) |
| Mar 2010 | - | $417.00K | $417.00K |
| Dec 2009 | $5.51M(-5.7%) | - | - |
| Dec 2008 | $5.84M | - | - |
FAQ
- What is Pacira BioSciences annual capital expenditures?
- What is the all time high annual CAPEX for Pacira BioSciences?
- What is Pacira BioSciences annual CAPEX year-on-year change?
- What is Pacira BioSciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Pacira BioSciences?
- What is Pacira BioSciences quarterly CAPEX year-on-year change?
- What is Pacira BioSciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Pacira BioSciences?
- What is Pacira BioSciences TTM CAPEX year-on-year change?
What is Pacira BioSciences annual capital expenditures?
The current annual CAPEX of PCRX is $10.64M
What is the all time high annual CAPEX for Pacira BioSciences?
Pacira BioSciences all-time high annual capital expenditures is $45.87M
What is Pacira BioSciences annual CAPEX year-on-year change?
Over the past year, PCRX annual capital expenditures has changed by -$4.53M (-29.85%)
What is Pacira BioSciences quarterly capital expenditures?
The current quarterly CAPEX of PCRX is $8.55M
What is the all time high quarterly CAPEX for Pacira BioSciences?
Pacira BioSciences all-time high quarterly capital expenditures is $14.41M
What is Pacira BioSciences quarterly CAPEX year-on-year change?
Over the past year, PCRX quarterly capital expenditures has changed by +$5.71M (+201.41%)
What is Pacira BioSciences TTM capital expenditures?
The current TTM CAPEX of PCRX is $16.35M
What is the all time high TTM CAPEX for Pacira BioSciences?
Pacira BioSciences all-time high TTM capital expenditures is $51.11M
What is Pacira BioSciences TTM CAPEX year-on-year change?
Over the past year, PCRX TTM capital expenditures has changed by +$4.92M (+43.00%)